Angstrom Medica bought by Mich. firm

OncoPep licenses cancer vaccine, moves to add $500K to Series A [February 13, 2012]

VBI Vaccines pulls in $2.2M debt round [February 13, 2012]

Synageva advances rare disease treatment [February 10, 2012]

Zalicus, Hydra team up on pain treatment [February 10, 2012]

Angstrom Medica Inc., a Woburn startup focused on nanomaterials to rebuild human bones, has been acquired by a Michigan company, according to the buyer.

Pioneer Surgical Technology Inc., a privately held medical devices firm in Marquette, Mich., said it has acquired Angstrom for an undisclosed sum.

Angstrom, with six employees, is expected to continue operations in Woburn as a wholly owned subsidiary of Pioneer.

Angstrom's lead product is a nanomaterial implant, called NanOss, designed to remodel over time into human bone, according to Pioneer. The U.S. Food and Drug Administration has approved the nanotechnology device.

Edward Ahn, CEO of Angstrom, said he plans to continue to lead the Woburn operation as a vice president in Pioneer's surgical orthobiologics division. He founded the company in 2001 with two fellow researchers from the Massachusetts Institute of Technology.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.